Most Recent

image: Online Platforms to Share Medical Data Launch

Online Platforms to Share Medical Data Launch

By Jenny Rood | April 1, 2015

The “Genes for Good” Facebook app and the Open Humans Network plan to recruit large numbers of volunteers for medical studies using social media.

0 Comments

image: Enzyme Improves CRISPR

Enzyme Improves CRISPR

By Kerry Grens | April 1, 2015

A smaller Cas9 protein enables in vivo genome engineering via viral vectors.

0 Comments

image: Book Excerpt from <em>p53</em>

Book Excerpt from p53

By Sue Armstrong | April 1, 2015

In Chapter 12, "Of Mice and Men," author Sue Armstrong recounts the point at which researchers moved from working with p53 in tissue culture to studying the gene in animal models.

0 Comments

image: Cancer Kismet

Cancer Kismet

By Jenny Rood | April 1, 2015

Fate mapping allows researchers to follow cancer progression from its cell type of origin.

1 Comment

image: Contributors

Contributors

By Jenny Rood | April 1, 2015

Meet some of the people featured in the April 2015 issue of The Scientist.

0 Comments

image: Control ALT, Delete Cancer

Control ALT, Delete Cancer

By Haroldo Silva, David Halvorsen, and Jeremy D. Henson | April 1, 2015

Treating cancer by shutting down the alternative lengthening of telomeres (ALT) pathway

1 Comment

image: In Custody

In Custody

By Wudan Yan | April 1, 2015

Expert tips for isolating and culturing cancer stem cells

1 Comment

image: Professional Marksman

Professional Marksman

By Anna Azvolinsky | April 1, 2015

Charles Sawyers, who began his research career just as the genetic details of human oncogenes were emerging, codeveloped Gleevec, the quintessential targeted cancer therapy.

0 Comments

image: Setbacks and Great Leaps

Setbacks and Great Leaps

By Sue Armstrong | April 1, 2015

The tale of p53, a widely studied tumor suppressor gene, illustrates the inventiveness of researchers who turn mishaps into discoveries.

1 Comment

image: The CAR T-Cell Race

The CAR T-Cell Race

By Vicki Brower | April 1, 2015

Tumor-targeting T-cell therapies are generating remarkable remissions in hard-to-beat cancers—and attracting millions of dollars of investment along the way.

2 Comments

Popular Now

  1. How to Separate the Science From the (Jerk) Scientist
  2. Could a Dose of Sunshine Make You Smarter?
  3. Prevalent Form of Childhood Leukemia May Be Preventable
  4. Conservation Biologist Ben Collen Dies of Bone Cancer